JPS4864088A - - Google Patents
Info
- Publication number
- JPS4864088A JPS4864088A JP10082271A JP10082271A JPS4864088A JP S4864088 A JPS4864088 A JP S4864088A JP 10082271 A JP10082271 A JP 10082271A JP 10082271 A JP10082271 A JP 10082271A JP S4864088 A JPS4864088 A JP S4864088A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10082271A JPS4864088A (en) | 1971-12-13 | 1971-12-13 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10082271A JPS4864088A (en) | 1971-12-13 | 1971-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4864088A true JPS4864088A (en) | 1973-09-05 |
Family
ID=14284014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10082271A Pending JPS4864088A (en) | 1971-12-13 | 1971-12-13 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4864088A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2804113A1 (en) * | 2000-01-26 | 2001-07-27 | Lipha | New 2,4-diamino-3,6-dihydro-1,3,5-triazine derivatives, useful for treating disorders associated with insulin resistance syndrome, e.g. diabetes, dislipidemia, obesity or arterial hypertension |
| DE102007054416A1 (en) | 2007-11-13 | 2009-05-14 | Studiengesellschaft Kohle Mbh | Process for the preparation of 3,6-dihydro-1,3,5-triazine derivatives for the treatment of diseases associated with insulin resistance syndrome |
| WO2010109015A1 (en) | 2009-03-26 | 2010-09-30 | Poxel | Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization |
| US11266652B2 (en) | 2018-06-06 | 2022-03-08 | Poxel Sa | Methods of treating subjects having diabetes with chronic kidney disease |
-
1971
- 1971-12-13 JP JP10082271A patent/JPS4864088A/ja active Pending
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ303445B6 (en) * | 2000-01-26 | 2012-09-19 | Merck Sante | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| WO2001055122A1 (en) * | 2000-01-26 | 2001-08-02 | Lipha | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| JP2003520858A (en) * | 2000-01-26 | 2003-07-08 | リファ | Amine-containing derivatives of dihydro-1,3,5-triazine and their therapeutic use |
| EA005378B1 (en) * | 2000-01-26 | 2005-02-24 | Лифа | Dihidro-1,3,5-triazine amine derivatives and their therapeutic uses |
| US7034021B2 (en) | 2000-01-26 | 2006-04-25 | Lipha | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| US7452883B2 (en) | 2000-01-26 | 2008-11-18 | Merck Sante | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| FR2804113A1 (en) * | 2000-01-26 | 2001-07-27 | Lipha | New 2,4-diamino-3,6-dihydro-1,3,5-triazine derivatives, useful for treating disorders associated with insulin resistance syndrome, e.g. diabetes, dislipidemia, obesity or arterial hypertension |
| EP1250328B2 (en) † | 2000-01-26 | 2010-04-21 | Merck Sante | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| US7767676B2 (en) | 2000-01-26 | 2010-08-03 | Merck Sante | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| DE102007054416A1 (en) | 2007-11-13 | 2009-05-14 | Studiengesellschaft Kohle Mbh | Process for the preparation of 3,6-dihydro-1,3,5-triazine derivatives for the treatment of diseases associated with insulin resistance syndrome |
| US8703940B2 (en) | 2007-11-13 | 2014-04-22 | Studiengesellschaft Kohle Mbh | Process for preparing 3,6-dihydro-1,3,5-triazine derivatives |
| WO2010109015A1 (en) | 2009-03-26 | 2010-09-30 | Poxel | Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization |
| US11266652B2 (en) | 2018-06-06 | 2022-03-08 | Poxel Sa | Methods of treating subjects having diabetes with chronic kidney disease |